$BODI
Beachbody Company, Inc. Stock $bodi

$bodi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000095017024029409 Filed on March 11, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$119.0M	$527.1M	$692.2M
YoY Change	-19.68%	-23.85%	-20.77%
Cost Of Revenue	$45.04M	$204.0M	$322.6M
YoY Change	-29.12%	-36.76%	-1.84%
Gross Profit	$73.97M	$323.1M	$369.6M
YoY Change	-12.58%	-12.58%	-32.19%
Gross Profit Margin	62.16%	61.29%	53.39%
Selling, General & Admin	$73.52M	$340.1M	$438.4M
YoY Change	-20.95%	-22.43%	-30.17%
% of Gross Profit	99.39%	105.26%	118.63%
Research & Development	$14.09M	$2.700M	$4.400M
YoY Change	-3.68%	-38.64%	-4.35%
% of Gross Profit	19.04%	0.84%	1.19%
Depreciation & Amortization	$15.44M	$39.57M	$74.85M
YoY Change	-28.5%	-47.13%	25.59%
% of Gross Profit	20.87%	12.25%	20.25%
Operating Expenses	$91.30M	$464.1M	$572.7M
YoY Change	-19.81%	-18.97%	-32.0%
Operating Profit	-$17.33M	-$141.0M	-$203.2M
YoY Change	-40.72%	-30.6%	-31.67%
Interest Expense	-$2.101M	$8.874M	$3.368M
YoY Change	-4.24%	163.48%	528.36%
% of Operating Profit
Other Income/Expense, Net	$1.371M	$1.747M	$958.0K
YoY Change	-64.74%	82.36%	-70.1%
Pretax Income	-$65.10M	-$152.6M	-$197.2M
YoY Change	40.15%	-22.63%	-19.14%
Income Tax	-$62.00K	$37.00K	-$3.053M
% Of Pretax Income
Net Earnings	-$65.04M	-$152.6M	-$194.2M
YoY Change	44.75%	-21.4%	-14.97%
Net Earnings / Revenue	-54.65%	-28.96%	-28.05%
Basic Earnings Per Share		-$24.47	-$0.63
Diluted Earnings Per Share	-$10.31	-$24.47	-$0.63
COMMON SHARES
Basic Shares Outstanding		6.239M	307.5M
Diluted Shares Outstanding		6.239M	307.5M

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.41M	$33.41M	$80.09M
YoY Change	-58.29%	-58.29%	-23.03%
Cash & Equivalents	$33.41M	$33.41M	$80.09M
Short-Term Investments
Other Short-Term Assets	$45.92M	$59.62M	$51.44M
YoY Change	17.01%	15.9%	-16.18%
Inventory	$24.98M	$24.98M	$54.06M
Prepaid Expenses	$10.72M
Receivables	$1.270M	$1.270M	$866.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$119.3M	$119.3M	$186.5M
YoY Change	-36.03%	-36.03%	-37.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.06M	$48.12M	$79.18M
YoY Change	-39.24%	-39.23%	-33.86%
Goodwill	$85.20M
YoY Change	-31.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.923M	$2.923M	$9.506M
YoY Change	-69.25%	-69.25%	24.28%
Total Long-Term Assets	$157.6M	$157.6M	$256.9M
YoY Change	-38.68%	-38.68%	-24.04%
TOTAL ASSETS
Total Short-Term Assets	$119.3M	$119.3M	$186.5M
Total Long-Term Assets	$157.6M	$157.6M	$256.9M
Total Assets	$276.8M	$276.8M	$443.4M
YoY Change	-37.56%	-37.56%	-30.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.66M	$10.66M	$17.94M
YoY Change	-40.59%	-40.59%	-62.92%
Accrued Expenses	$42.15M	$43.98M	$66.58M
YoY Change	-34.58%	-33.94%	-13.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.068M	$8.068M	$1.250M
YoY Change	545.44%	545.44%
Total Short-Term Liabilities	$165.2M	$165.2M	$184.6M
YoY Change	-10.53%	-10.53%	-21.84%
LONG-TERM LIABILITIES
Long-Term Debt	$21.49M	$21.49M	$39.74M
YoY Change	-45.91%	-45.91%
Other Long-Term Liabilities	$5.950M	$7.375M	$7.297M
YoY Change	49.54%	1.07%	-43.13%
Total Long-Term Liabilities	$27.44M	$28.87M	$47.03M
YoY Change	-37.23%	-38.62%	266.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$165.2M	$165.2M	$184.6M
Total Long-Term Liabilities	$27.44M	$28.87M	$47.03M
Total Liabilities	$194.1M	$194.1M	$231.9M
YoY Change	-16.29%	-16.29%	-8.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$571.9M
YoY Change	36.41%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$82.76M	$82.76M	$211.5M
YoY Change
Total Liabilities & Shareholders Equity	$276.8M	$276.8M	$443.4M
YoY Change	-37.56%	-37.56%	-30.46%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$65.04M	-$152.6M	-$194.2M
YoY Change	44.75%	-21.4%	-14.97%
Depreciation, Depletion And Amortization	$15.44M	$39.57M	$74.85M
YoY Change	-28.5%	-47.13%	25.59%
Cash From Operating Activities	-$7.957M	-$22.54M	-$47.17M
YoY Change	-22.22%	-52.22%	-78.08%
INVESTING ACTIVITIES
Capital Expenditures	$1.076M	$6.576M	$26.49M
YoY Change	-66.96%	-75.18%	-66.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$4.250M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$1.076M	-$10.83M	-$26.49M
YoY Change	-66.96%	-59.14%	-78.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.908M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.013M	-13.72M	47.56M
YoY Change	-655.82%	-128.84%	-87.83%
NET CHANGE
Cash From Operating Activities	-7.957M	-22.54M	-47.17M
Cash From Investing Activities	-1.076M	-10.83M	-26.49M
Cash From Financing Activities	4.013M	-13.72M	47.56M
Net Change In Cash	-5.020M	-46.68M	-26.96M
YoY Change	-64.67%	73.13%	-153.68%
FREE CASH FLOW
Cash From Operating Activities	-$7.957M	-$22.54M	-$47.17M
Capital Expenditures	$1.076M	$6.576M	$26.49M
Free Cash Flow	-$9.033M	-$29.11M	-$73.67M
YoY Change	-33.02%	-60.48%	-74.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001826889
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	us-gaap	Film Monetized On Its Own Amortization Expense Statement Of Income Extensible List FilmMonetizedOnItsOwnAmortizationExpenseStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2022	us-gaap	Film Monetized On Its Own Amortization Expense Statement Of Income Extensible List FilmMonetizedOnItsOwnAmortizationExpenseStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiability
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiability
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseRightOfUseAsset
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseRightOfUseAsset
CY2023Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseLiabilities
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseLiabilities
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseRightOfUseAsset
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.thebeachbodycompany.com/20231231#LeaseRightOfUseAsset
CY2023Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.02
CY2023Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.02
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39735
CY2023	dei	Entity Registrant Name EntityRegistrantName	The Beachbody Company, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3222090
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Continental Blvd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	El Segundo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90245
CY2023	dei	City Area Code CityAreaCode	310
CY2023	dei	Local Phone Number LocalPhoneNumber	883-9000
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	BODI
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	57754248
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	100000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33409000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80091000
CY2023Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	4250000
CY2023Q4	us-gaap	Inventory Net InventoryNet	24976000
CY2022Q4	us-gaap	Inventory Net InventoryNet	54060000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10715000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13055000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45923000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	39248000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	119273000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	186454000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45055000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74147000
CY2023Q4	body	Content Assets Net ContentAssetsNet	21359000
CY2022Q4	body	Content Assets Net ContentAssetsNet	34888000
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	85166000
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	133370000
CY2023Q4	body	Lease Right Of Use Asset LeaseRightOfUseAsset	3063000
CY2022Q4	body	Lease Right Of Use Asset LeaseRightOfUseAsset	5030000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2923000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9506000
CY2023Q4	us-gaap	Assets Assets	276839000
CY2022Q4	us-gaap	Assets Assets	443395000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10659000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17940000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42147000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64430000
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	97169000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	95587000
CY2023Q4	body	Lease Liability Current LeaseLiabilityCurrent	1835000
CY2022Q4	body	Lease Liability Current LeaseLiabilityCurrent	2150000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8068000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1250000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5325000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3283000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	165203000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	184640000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21491000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	39735000
CY2023Q4	body	Lease Liabilities LeaseLiabilities	1425000
CY2022Q4	body	Lease Liabilities LeaseLiabilities	3318000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	181000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5950000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3979000
CY2023Q4	us-gaap	Liabilities Liabilities	194079000
CY2022Q4	us-gaap	Liabilities Liabilities	231853000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1900000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1900000000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	654657000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	630738000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-571876000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-419235000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	37000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	82760000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211542000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276839000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	443395000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	527109000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	692199000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	204022000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	322626000
CY2023	us-gaap	Gross Profit GrossProfit	323087000
CY2022	us-gaap	Gross Profit GrossProfit	369573000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	282147000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	359987000
CY2023	body	Enterprise Technology And Development Expenses EnterpriseTechnologyAndDevelopmentExpenses	74407000
CY2022	body	Enterprise Technology And Development Expenses EnterpriseTechnologyAndDevelopmentExpenses	104363000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57932000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	78426000
CY2023	body	Gain Loss On Restructuring Activity GainLossOnRestructuringActivity	-6497000
CY2022	body	Gain Loss On Restructuring Activity GainLossOnRestructuringActivity	-10047000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40000000
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	3092000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	19907000
CY2023	us-gaap	Operating Expenses OperatingExpenses	464075000
CY2022	us-gaap	Operating Expenses OperatingExpenses	572730000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-140988000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-203157000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3168000
CY2023	body	Impairment Of Other Investment ImpairmentOfOtherInvestment	4000000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2679000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8322000
CY2023	us-gaap	Interest Expense InterestExpense	8874000
CY2022	us-gaap	Interest Expense InterestExpense	3368000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1747000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	958000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-152604000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-197245000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3053000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-152641000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194192000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.47
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-31.58
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-31.58
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6239000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6239000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6150000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6150000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-152641000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194192000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-360000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	55000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax	222000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax	108000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	78000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-105000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-60000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	58000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-152701000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-194134000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	385385000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194192000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	58000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	17620000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2854000
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	183000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211542000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-152641000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-60000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	23891000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	553000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1653000
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2178000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	82760000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-152641000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194192000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40000000
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	3092000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	19907000
CY2023	body	Impairment Of Other Investments ImpairmentOfOtherInvestments	4000000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39573000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74848000
CY2023	body	Amortization Of Content Assets AmortizationOfContentAssets	23755000
CY2022	body	Amortization Of Content Assets AmortizationOfContentAssets	24276000
CY2023	body	Provision For Inventory And Inventory Purchase Commitments ProvisionForInventoryAndInventoryPurchaseCommitments	10561000
CY2022	body	Provision For Inventory And Inventory Purchase Commitments ProvisionForInventoryAndInventoryPurchaseCommitments	39757000
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-222000
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-108000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2679000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8322000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	23891000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	17620000
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-191000
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2961000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1899000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	733000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1310000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	598000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3168000
CY2023	body	Change In Lease Assets ChangeInLeaseAssets	1967000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1219000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17508000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-41510000
CY2023	body	Increase Decrease In Content Assets IncreaseDecreaseInContentAssets	10226000
CY2022	body	Increase Decrease In Content Assets IncreaseDecreaseInContentAssets	19787000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2340000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2806000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4438000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4241000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7103000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-26705000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-20293000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8673000
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2163000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-9563000
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-415000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4593000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22537000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47173000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6576000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26493000
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	4250000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10826000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26493000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3162000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	308000
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	50000000
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	17000000
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	625000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2082000
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	553000
CY2023	body	Tax Withholding Payments For Vesting Of Restricted Stock TaxWithholdingPaymentsForVestingOfRestrictedStock	2178000
CY2022	body	Tax Withholding Payments For Vesting Of Restricted Stock TaxWithholdingPaymentsForVestingOfRestrictedStock	183000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4485000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4908000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13717000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47561000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	398000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-858000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-46682000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26963000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80091000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	107054000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33409000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80091000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5389000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2700000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8300000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	389000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	817000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2025000
CY2022	body	Warrants Issued In Relation To Term Loan WarrantsIssuedInRelationToTermLoan	5236000
CY2023	body	Change In Fair Value Of Term Loan Warrants Due To Amended Exercise Price ChangeInFairValueOfTermLoanWarrantsDueToAmendedExercisePrice	802000
CY2023	body	Paid In Kind Fee Recorded As Incremental Debt Issuance Cost PaidInKindFeeRecordedAsIncrementalDebtIssuanceCost	488000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that may impact the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates in our consolidated financial statements include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill and intangible assets, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Our actual results could differ from our estimates. We periodically review estimates and assumptions and we reflect the effects of changes, if any, in the consolidated financial statements in the period that they are determined.</span></p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1000000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5000000
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	4000000
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	0
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	31500000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	36900000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2700000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4400000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	200000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	600000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	527109000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	692199000
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.95
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	10354000
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	13380000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14622000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40680000
CY2023Q4	us-gaap	Inventory Net InventoryNet	24976000
CY2022Q4	us-gaap	Inventory Net InventoryNet	54060000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	10600000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	39800000
CY2023Q4	body	Deferred Partner Costs Current DeferredPartnerCostsCurrent	36169000
CY2022Q4	body	Deferred Partner Costs Current DeferredPartnerCostsCurrent	31270000
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6788000
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4527000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1270000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	866000
CY2023Q4	body	Others Current OthersCurrent	1696000
CY2022Q4	body	Others Current OthersCurrent	2585000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45923000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	39248000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	266346000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	276900000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	221291000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	202753000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45055000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74147000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1200000
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	0
CY2023	us-gaap	Depreciation Depreciation	34460000
CY2022	us-gaap	Depreciation Depreciation	56593000
CY2023Q4	us-gaap	Film Monetized On Its Own Capitalized Cost Released FilmMonetizedOnItsOwnCapitalizedCostReleased	21134000
CY2022Q4	us-gaap	Film Monetized On Its Own Capitalized Cost Released FilmMonetizedOnItsOwnCapitalizedCostReleased	34713000
CY2023Q4	us-gaap	Film Monetized On Its Own Capitalized Cost Production FilmMonetizedOnItsOwnCapitalizedCostProduction	225000
CY2022Q4	us-gaap	Film Monetized On Its Own Capitalized Cost Production FilmMonetizedOnItsOwnCapitalizedCostProduction	175000
CY2023Q4	us-gaap	Film Costs FilmCosts	21359000
CY2022Q4	us-gaap	Film Costs FilmCosts	34888000
CY2023Q4	us-gaap	Film Monetized On Its Own Released Film Expected Amortization Year One FilmMonetizedOnItsOwnReleasedFilmExpectedAmortizationYearOne	14400000
CY2023	body	Film Monetized On Its Own Released Film Percentage Of Expected Amortization FilmMonetizedOnItsOwnReleasedFilmPercentageOfExpectedAmortization	100
CY2023	body	Film Monetized On Its Own Released Film Maximum Amortization Term FilmMonetizedOnItsOwnReleasedFilmMaximumAmortizationTerm	P3Y
CY2023	us-gaap	Film Monetized On Its Own Amortization Expense FilmMonetizedOnItsOwnAmortizationExpense	23800000
CY2022	us-gaap	Film Monetized On Its Own Amortization Expense FilmMonetizedOnItsOwnAmortizationExpense	24300000
CY2023	body	Modified Content Assets Amortization ModifiedContentAssetsAmortization	2100000
CY2022Q4	us-gaap	Goodwill Goodwill	125166000
CY2021Q4	us-gaap	Goodwill Goodwill	125166000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40000000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Goodwill Goodwill	85166000
CY2022Q4	us-gaap	Goodwill Goodwill	125166000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40000000
CY2023Q4	us-gaap	Goodwill Goodwill	85200000
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	92600000
CY2023Q4	body	Percentage Of Decline In Stock Price PercentageOfDeclineInStockPrice	0.45
CY2023	body	Percentage Of Decline In Revenue PercentageOfDeclineInRevenue	0.24
CY2023	body	Percentage Of Decline In Revenue PercentageOfDeclineInRevenue	0.24
CY2023	body	Percentage Of Decline In Stock Price PercentageOfDeclineInStockPrice	0.68
CY2022Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	105050000
CY2023Q4	body	Finite Lived Intangible Assets Accumulated Amortization And Impairment FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment	105050000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	105050000
CY2022Q4	body	Finite Lived Intangible Assets Accumulated Amortization And Impairment FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment	96845000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8204000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5100000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18300000
CY2023Q4	body	Accrued Partner Costs AccruedPartnerCosts	13971000
CY2022Q4	body	Accrued Partner Costs AccruedPartnerCosts	14535000
CY2023Q4	body	Accrued Inventory Shipping And Fulfillment Payable AccruedInventoryShippingAndFulfillmentPayable	6869000
CY2022Q4	body	Accrued Inventory Shipping And Fulfillment Payable AccruedInventoryShippingAndFulfillmentPayable	11687000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4334000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20584000
CY2023Q4	body	Accrual Sales And Other Taxes AccrualSalesAndOtherTaxes	3963000
CY2022Q4	body	Accrual Sales And Other Taxes AccrualSalesAndOtherTaxes	4818000
CY2023Q4	body	Accrued Information Technology AccruedInformationTechnology	3176000
CY2022Q4	body	Accrued Information Technology AccruedInformationTechnology	2207000
CY2023Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	872000
CY2022Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	1176000
CY2023Q4	body	Accrued Customer Service Expenses Current AccruedCustomerServiceExpensesCurrent	437000
CY2022Q4	body	Accrued Customer Service Expenses Current AccruedCustomerServiceExpensesCurrent	956000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8525000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8467000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42147000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64430000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8068000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2500000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	24527000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	35095000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8068000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5960000
CY2023Q4	body	Debt Instrument Capitalized Paid In Kind Interest DebtInstrumentCapitalizedPaidInKindInterest	424000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21491000
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	100000
CY2023	body	Lessee Operating Lease Expiring Description LesseeOperatingLeaseExpiringDescription	leases facilities under noncancelable operating leases expiring through 2027
CY2023	body	Lessee Finance Lease Expiring Description LesseeFinanceLeaseExpiringDescription	certain equipment under a finance lease expiring in 2024.
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3300000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5300000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3100000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5000000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	100000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	100000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	73000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	192000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2097000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2150000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	202000
CY2023	body	Variable Lease Costs VariableLeaseCosts	301000
CY2022	body	Variable Lease Costs VariableLeaseCosts	566000
CY2023	body	Short Term Sublease Income ShortTermSubleaseIncome	32000
CY2022	body	Short Term Sublease Income ShortTermSubleaseIncome	127000
CY2023	us-gaap	Lease Cost LeaseCost	2459000
CY2022	us-gaap	Lease Cost LeaseCost	2991000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	8000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2319000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2195000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	121000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	153000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	420000
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.04
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.04
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2079000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2000
CY2023Q4	body	Lease Liability Payments Due Year One LeaseLiabilityPaymentsDueYearOne	2081000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	687000
CY2023Q4	body	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	687000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	712000
CY2023Q4	body	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	712000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	132000
CY2023Q4	body	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	132000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3610000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2000
CY2023Q4	body	Lease Liability Payments Due LeaseLiabilityPaymentsDue	3612000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	352000
CY2023Q4	body	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	352000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3258000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2000
CY2023Q4	body	Lease Liability LeaseLiability	3260000
CY2021Q4	body	Lessee Operating Lease Expiration Year LesseeOperatingLeaseExpirationYear	2025
CY2023	us-gaap	Inventory Firm Purchase Commitment Loss InventoryFirmPurchaseCommitmentLoss	0
CY2022	us-gaap	Inventory Firm Purchase Commitment Loss InventoryFirmPurchaseCommitmentLoss	2700000
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	17452000
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	1475000
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	100000
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	75000
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	75000
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	19177000
CY2023	body	Royalty Payments RoyaltyPayments	4600000
CY2023	us-gaap	Restructuring Costs RestructuringCosts	6500000
CY2022	us-gaap	Restructuring Costs RestructuringCosts	10000000
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	0
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	500000
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	469000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	6497000
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	6948000
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	18000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	10047000
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	9578000
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	469000
CY2023Q4	body	Number Of Shares Authorized NumberOfSharesAuthorized	2000000000
CY2023Q4	body	Par Value Of Shares Authorized ParValueOfSharesAuthorized	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The holder of each Class A common stock is entitled to one vote, the holder of each share of Class X common stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C common stock is not entitled to any voting powers.
CY2023Q4	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-06-13
CY2023Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3300000
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	At the 2023 Annual Shareholder Meeting, which was held on November 20, 2023, our stockholders approved an amendment to our second amended and restated certificate of incorporation to effect a reverse stock split of all of our issued and outstanding common stock by a ratio in the range of 1-for-10 to 1-for-50. On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. The reverse stock split ratio and the implementation and the timing of the reverse stock split were determined by our Board. The reverse stock split did not change the authorized number of shares or the par value of our common stock or preferred stock, but did effect a proportional adjustment to the number of common stock outstanding, the per share exercise price and the number of shares of common stock issuable upon the exercise of outstanding stock options, the number of shares of common stock issuable upon the vesting of restricted stock awards ("RSU's"), the number of shares of common stock under the Employee Stock Purchase Plan (the "ESPP"), the conversion rate of our outstanding warrants into common stock and the number of shares of common stock eligible for issuance under our 2021 Stock Plan (the "2021 Plan"). No fractional shares were issued in connection with the reverse stock split. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split.
CY2021Q4	body	Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivatives	-32000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	11000
CY2021Q4	us-gaap	Aoci Including Portion Attributable To Noncontrolling Interest Tax AociIncludingPortionAttributableToNoncontrollingInterestTax	-21000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	24000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-105000
CY2022	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-81000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-108000
CY2022	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-108000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	31000
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	31000
CY2022Q4	body	Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivatives	131000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-94000
CY2022Q4	us-gaap	Aoci Including Portion Attributable To Noncontrolling Interest Tax AociIncludingPortionAttributableToNoncontrollingInterestTax	37000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-334000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	78000
CY2023	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-256000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-222000
CY2023	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-222000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	-26000
CY2023	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-26000
CY2023Q4	body	Accumulated Other Comprehensive Income Loss Unrealized Gain Loss On Derivatives AccumulatedOtherComprehensiveIncomeLossUnrealizedGainLossOnDerivatives	-7000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-16000
CY2023Q4	us-gaap	Aoci Including Portion Attributable To Noncontrolling Interest Tax AociIncludingPortionAttributableToNoncontrollingInterestTax	-23000
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	318440
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2023Q2	body	Vesting Percentage Exercisable Of The First Four Anniversaries VestingPercentageExercisableOfTheFirstFourAnniversaries	0.25
CY2023	body	Consecutive Trading Day Period ConsecutiveTradingDayPeriod	P30D
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	79612
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	126.00
CY2020Q4	body	Warrants Vesting Percentage On Grant Date WarrantsVestingPercentageOnGrantDate	0.25
CY2020Q4	body	Warrants Vesting Percentage After One Year From Grant Date WarrantsVestingPercentageAfterOneYearFromGrantDate	0.25
CY2020Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23891000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17620000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	33100000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M28D
CY2023Q3	body	Number Of Employees Terminated NumberOfEmployeesTerminated	25
CY2023Q1	body	Number Of Employees Terminated NumberOfEmployeesTerminated	100
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	462000
CY2023Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	0
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	0
CY2023	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred	100000
CY2023	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1 DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1	P12M
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-154571000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-198245000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1967000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1000000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-152604000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-197245000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.011
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.011
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.014
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	31000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-113000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	202000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-115000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-141000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-228000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	92000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-23000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1963000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	71000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	870000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	143000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	128000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	191000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2961000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3053000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	200000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.172
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.242
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.055
CY2023	body	Effective Income Tax Rate Reconciliation Note Revaluation Percent EffectiveIncomeTaxRateReconciliationNoteRevaluationPercent	-0.006
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	181000
CY2023	body	Effective Income Tax Rate Reconciliation Nontaxable Gain On Warrant Liability EffectiveIncomeTaxRateReconciliationNontaxableGainOnWarrantLiability	0.004
CY2022	body	Effective Income Tax Rate Reconciliation Nontaxable Gain On Warrant Liability EffectiveIncomeTaxRateReconciliationNontaxableGainOnWarrantLiability	0.009
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.015
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	91585000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	74038000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	13358000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10652000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	12339000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	18525000
CY2023Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	11570000
CY2022Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	13240000
CY2023Q4	body	Deferred Tax Assets Capitalized Research Expense DeferredTaxAssetsCapitalizedResearchExpense	9592000
CY2022Q4	body	Deferred Tax Assets Capitalized Research Expense DeferredTaxAssetsCapitalizedResearchExpense	6057000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	6552000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4915000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3886000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3886000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1064000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1438000
CY2023Q4	body	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	837000
CY2022Q4	body	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	1663000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	546000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	4246000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4517000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2164000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	155846000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	140824000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5853000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	13377000
CY2023Q4	body	Deferred Tax Liabilities Content Assets DeferredTaxLiabilitiesContentAssets	4448000
CY2022Q4	body	Deferred Tax Liabilities Content Assets DeferredTaxLiabilitiesContentAssets	7408000
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1969000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	2425000
CY2023Q4	body	Deferred Tax Liabilities Rights Of Use Assets DeferredTaxLiabilitiesRightsOfUseAssets	750000
CY2022Q4	body	Deferred Tax Liabilities Rights Of Use Assets DeferredTaxLiabilitiesRightsOfUseAssets	1231000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13020000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	24441000
CY2023Q4	body	Net D Deferred Tax Assets Before Valuation Allowance NetDDeferredTaxAssetsBeforeValuationAllowance	142826000
CY2022Q4	body	Net D Deferred Tax Assets Before Valuation Allowance NetDDeferredTaxAssetsBeforeValuationAllowance	116383000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142836000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	116564000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	10000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1044000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	568000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	476000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1044000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1044000
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023Q4	body	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	1044000
CY2022Q4	body	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	1044000
CY2023	body	Employee Benefit Plans EmployeeBenefitPlans	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 19. Employee Benefit Plan</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains a defined contribution 401(k) plan for the benefit of all employees who have met the eligibility requirements. Participants may contribute up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of their eligible compensation, subject only to annual limitations set by the Internal Revenue Service. The Company matched </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of participant contributions, up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the participant’s total compensation. For the years ended December 31, 2023 and 2022, the Company recorded expense for matching contributions of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span></p>
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.75
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1900000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-152641000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194192000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6238777
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6238777
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6149784
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6149784
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.47
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-31.58
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-31.58
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	420769
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2562151
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1587091
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Firm AuditorFirmId	42

Files In Submission

Name	View Source	Status
0000950170-24-029409-index-headers.html	Edgar Link	pending
0000950170-24-029409-index.html	Edgar Link	pending
0000950170-24-029409.txt	Edgar Link	pending
0000950170-24-029409-xbrl.zip	Edgar Link	pending
body-20231231.htm	Edgar Link	pending
body-20231231.xsd	Edgar Link	pending
body-ex21_1.htm	Edgar Link	pending
body-ex23_1.htm	Edgar Link	pending
body-ex23_2.htm	Edgar Link	pending
body-ex31_1.htm	Edgar Link	pending
body-ex31_2.htm	Edgar Link	pending
body-ex32_1.htm	Edgar Link	pending
body-ex3_1.htm	Edgar Link	pending
body-ex97_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img27321737_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
body-20231231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BODI
Beachbody Company, Inc. Stock $bodi

2023 Q4 Form 10-K Financial Statement

#000095017024029409 Filed on March 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BODI Beachbody Company, Inc. Stock $bodi

2023 Q4 Form 10-K Financial Statement

#000095017024029409 Filed on March 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BODI
Beachbody Company, Inc. Stock $bodi